In a thorough study of the tumorigenic capacity of 14 different mutant forms of CTNNB1 with Yap-1, Zhang and colleagues showed that specific mutant forms of CTNNB1 determine HB tumor growth rates, survival, histologic features, metabolic features, and transcriptional profiles [55]. The gene discussed is CTNNB1; the disease is neoplasm.